Analyst Ratings for AstraZeneca (AZN) [Sells]

AZN Rating Summary

AZN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on AZN
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $63.75 (+10.1%) * Over Last 12-Mos
Rating Score: 6.1 / 10   Percentile Rank: 64%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/7/2017 HSBC N/A Downgrade
()
N/A
(N/A)
30.46
(57.89)
90.05% Details
4/12/2016 Goldman Sachs
» Updated 3/22/2021
Keyur Parekh Downgrade Sell
(Neutral)
N/A
(N/A)
29.09
(57.89)
99% Details
Like AZN Ratings? Also take a look at PFE, MRNA, JNJ, BNTX

AZN Ratings News